These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Artificial oxygen carriers -- a critical analysis of current developments]. Dinkelmann S; Northoff H Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):47-54. PubMed ID: 12522731 [No Abstract] [Full Text] [Related]
5. Present trends in fluorocarbon-based blood substitutes. Riess JG Life Support Syst; 1984; 2(4):273-6. PubMed ID: 6527557 [No Abstract] [Full Text] [Related]
6. Clinical experience with Fluosol-DA (20%) in the United States. Tremper KK; Levine EM; Waxman K Int Anesthesiol Clin; 1985; 23(1):185-97. PubMed ID: 3884514 [No Abstract] [Full Text] [Related]
7. Blood substitutes and oxygen therapeutics: an overview and current status. Jahr JS; Nesargi SB; Lewis K; Johnson C Am J Ther; 2002; 9(5):437-43. PubMed ID: 12237737 [TBL] [Abstract][Full Text] [Related]
10. It's not artificial blood--but can do the work of RBCs. Schwarz T RN (For Managers); 1982 Oct; 45(12):38-41. PubMed ID: 6921842 [No Abstract] [Full Text] [Related]
11. [Clinical application of fluorocarbon artificial blood in 10 cases (author's transl)]. Xiong RC Zhonghua Wai Ke Za Zhi; 1981 Apr; 19(4):213-5. PubMed ID: 7261781 [No Abstract] [Full Text] [Related]
12. Current status of oxygen carriers ('blood substitutes'): 2006. Winslow RM Vox Sang; 2006 Aug; 91(2):102-10. PubMed ID: 16907870 [TBL] [Abstract][Full Text] [Related]
13. Overview of progress in the fluorocarbon approach to in vivo oxygen delivery. Riess JG Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):183-202. PubMed ID: 1391434 [TBL] [Abstract][Full Text] [Related]
14. [Biophysics at the turn of the new millenium: perfluorocarbon media and gas-transporting blood substitutes]. Ivanitskiĭ GR Biofizika; 2001; 46(1):5-33. PubMed ID: 11236562 [TBL] [Abstract][Full Text] [Related]
16. Perfluorochemical "red blood cell substitutes": the continued search for an indication. Tremper KK Anesthesiology; 2002 Dec; 97(6):1333-4. PubMed ID: 12459656 [No Abstract] [Full Text] [Related]
17. Blood substitutes: where do we stand with the fluorocarbon approach? Riess JG Curr Surg; 1988; 45(5):365-70. PubMed ID: 3073041 [No Abstract] [Full Text] [Related]
18. [Microcirculatory indices in the experimental therapy of acute blood loss using a blood substitute--an oxygen carrier based on perfluorodecalin]. Matvienko VP; Gusenova FM; Afonin NI; Aprosin IuD; Sidliarov DP Gematol Transfuziol; 1983 Apr; 28(4):38-41. PubMed ID: 6852511 [No Abstract] [Full Text] [Related]
19. [The use of perfluorocarbon emulsions for suppression of rejection reaction in kidney allotransplantation]. Ilgiavishute IaS; Zhukauskas GIu; Dapshis KL; Onishchenko NA Khirurgiia (Mosk); 1993 May; (5):16-8. PubMed ID: 8089979 [TBL] [Abstract][Full Text] [Related]